Nicofuranose

Nicofuranose
Clinical data
ATC code
Identifiers
  • 1,3,4,6-tetrakis-O-(pyridin-3-ylcarbonyl)-β-D-fructofuranose
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.035.789 Edit this at Wikidata
Chemical and physical data
FormulaC30H24N4O10
Molar mass600.540 g·mol−1
3D model (JSmol)
  • C1=CC(=CN=C1)C(=O)OC[C@@H]2[C@H]([C@@H]([C@](O2)(COC(=O)C3=CN=CC=C3)O)OC(=O)C4=CN=CC=C4)OC(=O)C5=CN=CC=C5
  • InChI=1S/C30H24N4O10/c35-26(19-5-1-9-31-13-19)40-17-23-24(42-28(37)21-7-3-11-33-15-21)25(43-29(38)22-8-4-12-34-16-22)30(39,44-23)18-41-27(36)20-6-2-10-32-14-20/h1-16,23-25,39H,17-18H2/t23-,24-,25+,30-/m1/s1 ☒N
  • Key:FUWFSXZKBMCSKF-ZASNTINBSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Nicofuranose is a niacin derivative used as a hypolipidemic agent.[1]

References

  1. ^ Kopelevich VM, Gunar VI (1999). "Some approaches to the directed search for new drugs based on nicotinic acid". Pharm Chem J. 33 (4): 177–187. doi:10.1007/BF02509934.


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.